MARK COVINGTON

Allopathic & Osteopathic Physicians|Otolaryngology LEES SUMMIT, MO NPI 1740201599

General Payments — all program years on this page

$4,867.44

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 125
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $350.71 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $294.7014
Education $56.011

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $218.4613
2019 $2,935.3131
2020 $178.879
2021 $337.4216
2022 $443.4723
2023 $403.2018
2024 $350.7115

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086764409 Novartis Pharmaceuticals Corporation $26.63 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114030429 Regeneron Healthcare Solutions, Inc. $37.35 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114030431 Regeneron Healthcare Solutions, Inc. $56.01 08/14/2024 Education Undisputed 01/23/2026 View at CMS
1115858836 GlaxoSmithKline, LLC. $15.38 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116179692 GlaxoSmithKline, LLC. $23.45 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116270652 GlaxoSmithKline, LLC. $14.89 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116494958 GlaxoSmithKline, LLC. $14.73 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134080868 Ambu Inc. $24.90 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139999649 GENZYME CORPORATION $27.30 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139999655 GENZYME CORPORATION $26.69 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139999665 GENZYME CORPORATION $5.22 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139999673 GENZYME CORPORATION $5.32 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139999677 GENZYME CORPORATION $21.85 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139999695 GENZYME CORPORATION $26.72 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139999697 GENZYME CORPORATION $24.27 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.